Clinical Trials
205 trialsCASCADE3001A
UNC Lineberger Comprehensive Cancer Center
PRIORITY
Pontificia Universidad Catolica de Chile
Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
Amplexd Therapeutics, Inc.
SHIP-A-S01
National Cancer Institute (NCI)
LMI-001-A-S03
National Cancer Institute (NCI)
LMI-001-A-S02
National Cancer Institute (NCI)
LMI-001-A-S04
National Cancer Institute (NCI)
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
University of California, Los Angeles
ASCEND
UNC Lineberger Comprehensive Cancer Center
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Washington University School of Medicine
HBM-HPV
Yuzuncu Yil University
PaPCR
University Hospital, Brest
KOPRETINA
The Institute of Molecular and Translational Medicine, Czech Republic
POC
Basic Health International, Inc.
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
National Cancer Institute (NCI)
(iSTAR)
Columbia University
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
ASHA-Health II
University of California, Irvine
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
The Institute of Molecular and Translational Medicine, Czech Republic
RIFT-SSA
Institut d'Investigació Biomèdica de Bellvitge
EQUIP
Qurasense
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
University Hospital Tuebingen
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
University Hospital, Geneva
Merck-4
Indiana University
PopSci CHW4CervixHealth
Thomas Jefferson University
Pocket Colposcopy Using CARE Algorithm
Duke University
PDT for CIN2
Second Affiliated Hospital, School of Medicine, Zhejiang University
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
Karolinska Institutet
HPV-VG1
Ruhr University of Bochum
ULACNet-202
Weill Medical College of Cornell University
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
Mayo Clinic
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
Baylor College of Medicine
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
University of Bern
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
Ohio State University Comprehensive Cancer Center
PRESTIS
Baylor College of Medicine
HPV-RWS
Peking University
ART-VIN IIB
Frantz Viral Therapeutics, LLC
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
UNC Lineberger Comprehensive Cancer Center
HPV
International Vaccine Institute
Isbaar
University of Minnesota
START-001
Marengo Therapeutics, Inc.
HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
Zhujiang Hospital
TREVINO
Tampere University Hospital
1:1 Comparison of the Pocket Colposcope in Kenya
Duke University
What is the Optimal Training Model for Cervical Awareness?
Izmir City Hospital
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
First Affiliated Hospital of Wenzhou Medical University
Multimodality Treatments of HPV-related Lesions of the Female Genital Tract
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
ORGANOIDES
Centre Hospitalier Régional d'Orléans